Breaking
Friday, June 19, 2026

Clinical Trials Analysis

🇪🇺 EMA

Expert commentary and market intelligence for pharma strategy teams

Showing 1–12 of 43 articles

Critical impact AnalysisJun 11, 2026

Europe Drug Prices Face Pressure as U.S. Benchmarking Tightens

5 min

Dr. Elena Rossi
High impact AnalysisJun 6, 2026

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

4 min

Dr. Elena Rossi
High impact AnalysisJun 6, 2026

European Cancer Guidelines Add Delcath Liver Therapy for Eye Melanoma

oncology · 5 min

Dr. Elena Rossi
High impact AnalysisJun 6, 2026

New EU Template for Clinical Trial Recruitment and Informed Consent: What Pharma Teams Need to Know

EMA · 5 min

Dr. Elena Rossi
High impact AnalysisJun 5, 2026

Health News Round Up: Diabetes, Vaping, and Biologics – What Pharma Teams Need to Know

diabetes · 5 min

Dr. Elena Rossi
High impact AnalysisJun 5, 2026

Staff Stick: A B2B Guide to the Dual Meaning and Pharma Context

5 min

Dr. Elena Rossi
High impact AnalysisJun 5, 2026

Nika Pharmaceuticals Inc OTCQB NIKA June 2026 Update: Key Developments and Strategic Implications

5 min

Dr. Elena Rossi
High impact AnalysisJun 4, 2026

Japan Grants Orphan Status to QRX003 for Netherton Syndrome: Implications for Pharma Teams

MHLW · Netherton syndrome · 5 min

Dr. Elena Rossi
High impact AnalysisJun 4, 2026

Lilly to Spotlight Growing Hematology Portfolio at 2026 EHA Annual Meeting: Key Data and Strategic Implications

EMA · 6 min

Dr. Elena Rossi
High impact AnalysisJun 4, 2026

BBIA Joins EuropaBio: Strengthening the Bio-Based Economy for Pharma and Industry

4 min

Dr. Elena Rossi
High impact AnalysisJun 4, 2026

Kaléo's Initiative on Allergy Awareness: Amplifying Patient Stories

FDA · allergy · 5 min

Dr. Elena Rossi
Critical impact AnalysisJun 3, 2026

Favipiravir Shipment to Europe Signals Hantavirus Preparedness Amidst Cruise Ship Outbreak

hantavirus · 7 min

Dr. Elena Rossi